Search - tctmd.com

Displaying 221 - 240 of 528

Sort: Relevancy | Date

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Industry News

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

May 07, 2019

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Todd Neale

May 01, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

Caitlin E. Cox

April 12, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

Presentation ECHO/IMAGING 2019

Transcatheter Valve Interventions - The Central Role of Imaging

Presenter: Mackram F. Eleid

March 23, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

Presentation JIM 2019

Complications in Trans-Catheter Valve and Structural Heart Disease Interventions

Presenter: Maurice Buchbinder

February 14, 2019

News Conference News STS 2019

TAVR-Related Complications, High Resource Use Decreasing at a Surgeon-Led Program

Yael L. Maxwell

January 30, 2019

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

L.A. McKeown

January 21, 2019

News Daily News

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

Yael L. Maxwell

January 11, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Daily News

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Todd Neale

January 09, 2019

News Daily News

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

Caitlin E. Cox

January 04, 2019

News Features

Top News in Structural Heart Disease: 2018

L.A. McKeown

December 28, 2018

News Daily News

Better TAVR Outcomes With More Experienced Operators: New York Database

Michael O'Riordan

December 12, 2018

Advertisement

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Latest Observational Data Support TAVR Durability Through 7 Years

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Transcatheter Valve Interventions - The Central Role of Imaging

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Complications in Trans-Catheter Valve and Structural Heart Disease Interventions

TAVR-Related Complications, High Resource Use Decreasing at a Surgeon-Led Program

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

Top News in Structural Heart Disease: 2018

Better TAVR Outcomes With More Experienced Operators: New York Database

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content